SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

LEVAN ALAN B

(Last)

(First)

(Middle)

1750 E. SUNRISE BLVD.

(Street)

FT. LAUDERDALE

33304

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
BANKATLANTIC BANCORP INC [ BBX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman of the Board and CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/06/2004

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Options to Buy Class A Common Stock	$7.4103⁽¹⁾	01/06/2004		A⁽²⁾		18,377⁽²⁾		03/31/2008	03/31/2013	Class A Common Stock	18,377	$0	78,377	D
Options to Buy Class A Common Stock	$8.5585⁽³⁾	01/06/2004		A⁽²⁾		18,377⁽²⁾		03/04/2007	03/04/2012	Class A Common Stock	18,377	$0	78,377	D
Options to Buy Class A Common Stock	$2.9664⁽⁴⁾	01/06/2004		A⁽²⁾		5,066⁽²⁾		01/02/2006	01/02/2011	Class A Common Stock	5,066	$0	21,606	D
Options to Buy Class A Common Stock	$3.263⁽⁵⁾	01/06/2004		A⁽²⁾		7,185⁽²⁾		01/01/2006	01/02/2006	Class A Common Stock	7,185	$0	30,645	D
Options to Buy Class A Common Stock	$1.7306⁽⁶⁾	01/06/2004		A⁽²⁾		120,932⁽²⁾		⁽⁷⁾	06/01/2004	Class A Common Stock	120,932	$0	515,752	D
Options to Buy Class A Common Stock	$1.7741⁽⁸⁾	01/06/2004		A⁽²⁾		120,935⁽²⁾		⁽⁷⁾	04/04/2005	Class A Common Stock	120,935	$0	515,766	D
Options to Buy Class A Common Stock	$2.8232⁽⁹⁾	01/06/2004		A⁽²⁾		10,828⁽²⁾		05/02/2005	05/02/2010	Class A Common Stock	10,828	$0	46,180	D
Options to Buy Class A Common Stock	$3.1057⁽¹⁰⁾	01/06/2004		A⁽²⁾		7,549⁽²⁾		05/02/2005	05/02/2010	Class A Common Stock	7,549	$0	32,197	D
Options to Buy Class A Common Stock	$4.7429⁽¹¹⁾	01/06/2004		A⁽²⁾		21,134⁽²⁾		04/06/2004	04/06/2009	Class A Common Stock	21,134	$0	90,134	D
Options to Buy Class A Common Stock	$6.3239⁽¹²⁾	01/06/2004		A⁽²⁾		4,281⁽²⁾		⁽⁷⁾	08/04/2008	Class A Common Stock	4,281	$0	18,259	D
Options to Buy Class A Common Stock	$5.2722⁽¹³⁾	01/06/2004		A⁽²⁾		33,022⁽²⁾		⁽⁷⁾	05/06/2007	Class A Common Stock	33,022	$0	140,835	D
Options to Buy Class A Common Stock	$3.8172⁽¹⁴⁾	01/06/2004		A⁽²⁾		51,598⁽²⁾		⁽⁷⁾	07/09/2006	Class A Common Stock	51,598	$0	220,056	D

Explanation of Responses:

1. The exercise price of these previously granted and reported stock options was adjusted from $9.68 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).

2. Reflects an adjustment in the number of shares issuable under previously granted and reported stock options by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).

3. The exercise price of these previously granted and reported stock options was adjusted from $11.18 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).

4. The exercise price of these previously granted and reported stock options was adjusted from $3.875 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).

5. The exercise price of these previously granted and reported stock options was adjusted from $4.2625 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).

6. The exercise price of these previously granted and reported stock options was adjusted from $2.2607 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).

7. Options are currently exercisable.

8. The exercise price of these previously granted and reported stock options was adjusted from $2.3175 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).

9. The exercise price of these previously granted and reported stock options was adjusted from $3.688 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).

10. The exercise price of these previously granted and reported stock options was adjusted from $4.057 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).

11. The exercise price of these previously granted and reported stock options was adjusted from $6.1957 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).

12. The exercise price of these previously granted and reported stock options was adjusted from $8.2609 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).

13. The exercise price of these previously granted and reported stock options was adjusted from $6.887 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).

14. The exercise price of these previously granted and reported stock options was adjusted from $4.9864 by the Issuer's Compensation Committee pursuant to anti-dilution provisions contained in the relevant Issuer stock option plan to reflect the Issuer's spin-off of its interest in Levitt Corporation to the Issuer's shareholders, which adjustment is exempt from Section 16(b).

Remarks:

	Alan B. Levan	01/06/2004
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.